Phase II Study of ACNU in Non-Small-Cell Lung Cancer: EORTC Study 08872

Lung Cancer - Netherlands
doi 10.1016/0169-5002(91)90443-a
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

A Phase II Study of High Dose Epirubicin in Unresectable Non Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

Oncology Letters
Cancer ResearchOncology
2010English

Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses

British Journal of Cancer
Cancer ResearchOncology
2000English

Phase II Study of Nitrosourea Fotemustine as Single-Drug Chemotherapy in Poor-Prognosis Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1994English

Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study

Research in Oncology
2007English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2016English

OA01.05 Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Phase II Study of Gemcitabine Plus Oxaliplatin as First-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

A Phase II Study of Oral Etoposide in Elderly Patients With Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy